Published in Acta Biol Med Ger on January 01, 1979
Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha. Acta Virol (1989) 0.86
An interferon like substance induced by mannans. Acta Virol (1967) 0.85
Double-stranded f 2 phage RNA as interferon inducer. Acta Virol (1971) 0.82
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha. Immunology (1991) 0.81
Electrophoretic profiles and activities of human interferon in heterologous cells. Intervirology (1974) 0.81
Release of interferon by mouse peritoneal cells in vitro. The requirement of contact with endotoxin and the temperature dependence of release. Acta Virol (1969) 0.81
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Enhancing effect of anti-endotoxic serum on interferon induction in mouse peritoneal cells by endotoxin. Acta Virol (1968) 0.81
A novel Notch3 Gly89Cys mutation in a Serbian CADASIL family. Acta Neurol Belg (2013) 0.79
Activation of NK cells in subjects exposed to mild hyper- or hypothermic load. J Interferon Res (1988) 0.79
Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.78
The reticuloendothelial system and virus infection. II. Production of interferon- and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch Gesamte Virusforsch (1965) 0.78
Experimental pathogenesis of A-equi 1 influenza virus infection in horses. Acta Virol (1966) 0.78
Interferon as therapeutic agent. Acta Virol (1983) 0.78
Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats. Am J Med Sci (2000) 0.78
Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon. Acta Virol (1986) 0.78
Activation of the complement system by interferon inducers. Acta Virol (1972) 0.78
The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol (1967) 0.78
Human acid- and thermolabile alpha-interferon-like substance: selective reactivity with a monoclonal antibody. Antiviral Res (1989) 0.78
The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma (1977) 0.77
Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol (1972) 0.77
Are the acid-labile interferon alpha and interferon omega-1 identical? Virology (1991) 0.77
Current view on the perspectives of interferon therapy. Acta Virol (1986) 0.77
Therapeutic use of double-stranded RNAs in man. Tex Rep Biol Med (1983) 0.77
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies. Acta Virol (1976) 0.77
Stimulation of interferon production by mannans. Proc Soc Exp Biol Med (1970) 0.76
Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Acta Virol (1989) 0.76
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Immunol Lett (1993) 0.76
Effect of impulsin treatment of interferon production and antiviral resistance of mice. Arch Immunol Ther Exp (Warsz) (1977) 0.76
Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Mol Immunol (1992) 0.76
Blood-brain barrier permeability changes during acute allergic encephalomyelitis induced in the guinea pig. Metab Brain Dis (1989) 0.76
[N[2-hydroxyethyl] palmitamide repeated administration effect on interferon production in mouse organism after phage double-stranded ribonucleic acid [ds-RNA] application (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1978) 0.76
Interactions between viral infection and immune mechanisms. Comp Immunol Microbiol Infect Dis (1980) 0.75
Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch Immunol Ther Exp (Warsz) (1995) 0.75
Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med (1977) 0.75
Antigenic link between human interferons-alpha and -beta: the common epitope 1. J Interferon Res (1990) 0.75
Long-term culture of guinea pig tongue cells: a suitable interferon system. Acta Virol (1979) 0.75
Production of interferon and other lymphokines during murine tumour growth. III. Characterization of microbial growth inhibitory activity in cell-free supernatants of rat Zajdela ascites hepatoma. Acta Virol (1982) 0.75
Some properties of interferon released by mouse peritoneal leukocytes stimulated with endotoxin, mannan and Newcastle disease virus in vitro. Acta Virol (1970) 0.75
Interferon-like and antibody-like substances in mouse peritoneal cells stimulated by myxoviruses in vivo. Acta Virol (1965) 0.75
[Interferon. Experiences and perspectives]. Cas Lek Cesk (1968) 0.75
Patterns of interferon induction in leuckocytes. Acta Microbiol Pol A (1973) 0.75
Increased effects of topically applied interferon on herpes simplex virus-induced lesions by caffeine. Acta Virol (1995) 0.75
Results of a five-year study of the curative effect of double stranded ribonucleic acid in viral dermatoses and eye diseases. Adv Exp Med Biol (1978) 0.75
Urinary proteins inhibit fibroblast proliferation. Gen Pharmacol (1979) 0.75
Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma. Acta Virol (1988) 0.75
Accelerated appearance of an ascitic tumour after long-term application of interferon to NZB/W mice. Acta Virol (1981) 0.75
[Interferon 1981. The present state of research and therapeutic utilization (author's transl)]. Cas Lek Cesk (1981) 0.75
[Systems approach to interferon as an anticancer agent]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[A hyperthermic bath increases the cytolytic activity of NK cells]. Cas Lek Cesk (1987) 0.75
Release of an interferon-like virus inhibitor during contact of mouse leukocytes with target cells. Acta Virol (1970) 0.75
Preparation of highly sensitive mouse hybrid cells for interferon assays. J Immunol Methods (1989) 0.75
Antiviral and cell-growth inhibitory effect of interferon. Biomedicine (1973) 0.75
Inhibitory effect of interferon on cell fusion by Sendai virus and polyethylene glycol. Acta Virol (1983) 0.75
[Interferon as a therapeutic agent]. Cesk Farm (1982) 0.75
In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test. Neoplasma (1993) 0.75
Comparison on interferon production in mouse leukocytes by statolon and a complexed polyribonucleotide (poly I:C). Acta Virol (1970) 0.75
[Use of leukocytic concentrate for preparing human interferon (author's transl)]. Bratisl Lek Listy (1977) 0.75
Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1. Vet Immunol Immunopathol (1993) 0.75
Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35. J Interferon Res (1991) 0.75
[Interferon formation in hairy cell leukemia]. Cas Lek Cesk (1987) 0.75
[Peritoneal macrophages and interferon formation (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1974) 0.75
[Treatment of juvenile papillomatosis of the larynx using interferon and levamisole]. Cesk Otolaryngol (1986) 0.75
Properties of the inferferon-like virus inhibitor released during interaction of mouse sensitized lymphocytes with their target cells. Eur J Immunol (1971) 0.75
Contribution to the problem of purity of interferon preparations. Acta Virol (1973) 0.75
Evaluation of the Czechoslovak double-stranded RNA preparation as inducer of interferon in model experiments. Acta Virol (1972) 0.75
Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons. Acta Virol (1990) 0.75
Murine monoclonal antibodies against human fibroblast (beta) interferon. Correlation of the neutralization of antiviral and antiproliferative activities. Acta Virol (1989) 0.75
The interferon system: characterization of intraspecific mouse hybrids. Acta Virol (1982) 0.75
Clinical and immunological characterization of systemic lupus erythematosus in patients with circulating interferon and migration inhibitory factor. Int J Clin Pharmacol Res (1984) 0.75
Increased resistance of an interferon-resistant cell subline to the toxic effect of double-stranded RNA. Acta Virol (1976) 0.75
Surface properties of the egg and mouse lines of A1 influenza virus. J Immunol (1965) 0.75
Preparation and characterization of hybridomas secreting monoclonal antibodies to tick-borne encephalitis virus. Acta Virol (1986) 0.75
The syndrome of adaptation of influenza viruses to laboratory animals. J Hyg Epidemiol Microbiol Immunol (1966) 0.75
[The effect of viruses on the immune system]. Bratisl Lek Listy (1987) 0.75
Relation of incubation temperature to interferon production in mouse peritoneal cells infected with Newcastle disease virus. Acta Virol (1969) 0.75
[Double stranded RNA and a nonspecific stimulator of the organism's defense mechanism]. Bratisl Lek Listy (1978) 0.75
Partial heterologous tolerance to interferon production in mice infected with B. pertussis. Acta Virol (1966) 0.75
[Interferon and similar substances. Current status of research]. Cesk Epidemiol Mikrobiol Imunol (1966) 0.75
Interferon-induced changes in the expression and topography of H-2 antigens and receptors for SRBC in tumour cells. Folia Biol (Praha) (1982) 0.75
Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness. Acta Virol (1988) 0.75
Mercaptoethanol sensitivity of interferons produced in various compartments of the mouse organism. Acta Virol (1966) 0.75
[Clinical experience with double stranded ribonucleic acid inducing interferon (author's translation)]. Cas Lek Cesk (1977) 0.75
Persistent infection of BHK cells with herpes simplex virus types 1 and 2 in the absence of specific anti-herpetic antibody. Acta Virol (1976) 0.75
[Effect of sodium chloride on the secretory activity on the kidney juxtaglomerular cells and on the adrenal glomerular zone in the adult male rabbit]. Bull Assoc Anat (Nancy) (1978) 0.75
[Production of gamma interferon and interleukin 2 in mononuclear spleen cells stimulated with concanavalin A]. Vopr Virusol (1985) 0.75
Enhancement of interferon production by lowered temperature and-or cyclohexximide in endotoxin-stimulated mouse leukocytes. Acta Virol (1972) 0.75